Natalia Elizalde
Natalia graduated in pharmacy, developing her end of degree project at UCLH Hospital in London. Afterwards, she was awarded a European PhD as a result of a thesis (University of Navarra; Oxford University) which focused on the long-term effects of chronic mild stress over behaviour and neurobiological markers (Extraordinary Doctorate award).
After her PhD, Natalia has specialised in business development in the biotech sector for over 12 years assuming various roles, first as Business Development Manager in a biotech company specialised in the zebrafish animal model, and as Head of Business Development at a CDMO developing and manufacturing biologicals and cell therapy products.
Natalia is responsible for VIVEbiotech´s business development strategy with respect to the international market.
ArticleThe rising demand for lentiviral vectors for in vivo gene therapy
Fuelled by advances in rare disease treatments and vaccination efforts, Natalia Elizalde, CBO at VIVEbiotech, discusses how the market demand for lentiviral vectors is evolving, the new therapeutic areas emerging as potential targets for in vivo gene therapy and the latest technological advancements in the development and delivery of in ...